Evidence map›Paper›PMID 24349113›Full record

ArticlePloS one2013

A quantitative comparison of human HT-1080 fibrosarcoma cells and primary human dermal fibroblasts identifies a 3D migration mechanism with properties unique to the transformed phenotype.

Michael P Schwartz, Robert E Rogers, Samir P Singh, Justin Y Lee, Samuel G Loveland, Justin T Koepsel, Eric S Witze, Sara I Montanez-Sauri, Kyung E Sung, Emi Y Tokuda and 8 more

Abstract readComparative Study
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Michael P SchwartzDepartment of Biomedical Engineering, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
Robert E RogersCollege of Medicine, Texas A&M Health Science Center, Bryan, Texas, United States of America.
Samir P SinghDepartment of Chemical and Biological Engineering, University of Colorado at Boulder, Boulder, Colorado, United States of America.
Justin Y LeeDepartment of Chemical and Biological Engineering, University of Colorado at Boulder, Boulder, Colorado, United States of America.
Samuel G LovelandDepartment of Biomedical Engineering, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
Justin T KoepselDepartment of Biomedical Engineering, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
Eric S WitzeDepartment of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, , United States of America.
Sara I Montanez-SauriMaterials Science Program, University of Wisconsin-Madison, Madison, Wisconsin, United States of America ; Paul P. Carbone Comprehensive Cancer Center, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
Kyung E SungDepartment of Biomedical Engineering, University of Wisconsin-Madison, Madison, Wisconsin, United States of America ; Paul P. Carbone Comprehensive Cancer Center, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
Emi Y TokudaDepartment of Chemical and Biological Engineering, University of Colorado at Boulder, Boulder, Colorado, United States of America.
Yasha SharmaDepartment of Biomedical Engineering, Boston University, Boston, Massachusetts, United States of America.
Lydia M EverhartDepartment of Chemical and Materials Engineering, University of Dayton, Dayton, Ohio, United States of America.
Eric H NguyenDepartment of Biomedical Engineering, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
Muhammad H ZamanDepartment of Biomedical Engineering, Boston University, Boston, Massachusetts, United States of America.
David J BeebeDepartment of Biomedical Engineering, University of Wisconsin-Madison, Madison, Wisconsin, United States of America ; Paul P. Carbone Comprehensive Cancer Center, University of Wisconsin-Madison, Madison, Wisconsin, United States of America ; Laboratory for Optical and Computational Instrumentation, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
Natalie G AhnDepartment of Chemistry and Biochemistry, University of Colorado at Boulder, Boulder, Colorado, United States of America ; Howard Hughes Medical Institute, University of Colorado at Boulder, Boulder, Colorado, United States of America.
William L MurphyDepartment of Biomedical Engineering, University of Wisconsin-Madison, Madison, Wisconsin, United States of America ; Department of Orthopedics and Rehabilitation, University of Wisconsin-Madison, Madison, Wisconsin, United States of America ; Materials Science Program, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
Kristi S AnsethDepartment of Chemical and Biological Engineering, University of Colorado at Boulder, Boulder, Colorado, United States of America ; Howard Hughes Medical Institute, University of Colorado at Boulder, Boulder, Colorado, United States of America.

Funding

Predoctoral Training Molecular BiophysicsT32GM065103 · NIGMS · UNIVERSITY OF COLORADO AT BOULDER · PI FALKE, JOSEPH J · 2002 to 2021
$4.3M
Biomaterials for local regulation of growth factor signalingR01HL093282 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI MURPHY, WILLIAM L. · 2009 to 2018
$3.3M
Understanding cell migration through microscale in vitro modelsR01EB010039 · NIBIB · UNIVERSITY OF WISCONSIN-MADISON · PI BEEBE, DAVID J, HUTTENLOCHER, ANNA · 2011 to 2014
$1.7M
Quantitative Analysis of Tumor Cell Migration in Three Dimensioinal MatricesR01CA132633 · NCI · UNIVERSITY OF TEXAS AT AUSTIN · PI ANSETH, KRISTI S., ZAMAN, MUHAMMAD HAMID · 2008 to 2011
$1.5M
Microchannel cell-based assays to enable cancer researchR33CA137673 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI BEEBE, DAVID J · 2009 to 2011
$1.4M
NCI NIH HHS R01 CA132633NCI NIH HHS R33 CA137673NHLBI NIH HHS R01 HL093282NIBIB NIH HHS R01 EB010039NIGMS NIH HHS T32 GM065103
6 · The paper itself

Abstract

Here, we describe an engineering approach to quantitatively compare migration, morphologies, and adhesion for tumorigenic human fibrosarcoma cells (HT-1080s) and primary human dermal fibroblasts (hDFs) with the aim of identifying distinguishing properties of the transformed phenotype. Relative adhesiveness was quantified using self-assembled monolayer (SAM) arrays and proteolytic 3-dimensional (3D) migration was investigated using matrix metalloproteinase (MMP)-degradable poly(ethylene glycol) (PEG) hydrogels ("synthetic extracellular matrix" or "synthetic ECM"). In synthetic ECM, hDFs were characterized by vinculin-containing features on the tips of protrusions, multipolar morphologies, and organized actomyosin filaments. In contrast, HT-1080s were characterized by diffuse vinculin expression, pronounced β1-integrin on the tips of protrusions, a cortically-organized F-actin cytoskeleton, and quantitatively more rounded morphologies, decreased adhesiveness, and increased directional motility compared to hDFs. Further, HT-1080s were characterized by contractility-dependent motility, pronounced blebbing, and cortical contraction waves or constriction rings, while quantified 3D motility was similar in matrices with a wide range of biochemical and biophysical properties (including collagen) despite substantial morphological changes. While HT-1080s were distinct from hDFs for each of the 2D and 3D properties investigated, several features were similar to WM239a melanoma cells, including rounded, proteolytic migration modes, cortical F-actin organization, and prominent uropod-like structures enriched with β1-integrin, F-actin, and melanoma cell adhesion molecule (MCAM/CD146/MUC18). Importantly, many of the features observed for HT-1080s were analogous to cellular changes induced by transformation, including cell rounding, a disorganized F-actin cytoskeleton, altered organization of focal adhesion proteins, and a weakly adherent phenotype. Based on our results, we propose that HT-1080s migrate in synthetic ECM with functional properties that are a direct consequence of their transformed phenotype.

Indexed as

Cell Transformation, NeoplasticPhenotypeActinsCD146 AntigenCell AdhesionCell Culture TechniquesCell Line, TumorCell MovementExtracellular MatrixFibroblastsGene ExpressionHumansHydrogelsIntegrin beta1Matrix MetalloproteinasesMolecular MimicryActinsCD146 AntigenHydrogelsIntegrin beta1Matrix MetalloproteinasesMCAM protein, humanVCL protein, humanVinculin

Identifiers

PMID24349113
PMCPMC3857815

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.